Genetic Testing for Familial Hypercholesterolemia: Health Technology Assessment [0.03%]
遗传性高胆固醇血症的基因检测：健康技术评估
Ontario Health (Quality)
Ontario Health (Quality)
Background: Familial hypercholesterolemia (FH) is an inherited disorder characterized by abnormally elevated low-density lipoprotein (LDL) cholesterol serum levels from birth, which increases the risk of premature atheros...
Molecular Testing for Thyroid Nodules of Indeterminate Cytology: A Health Technology Assessment [0.03%]
甲状腺细胞学结果不确定的结节进行分子检测：一项健康技术评估报告摘要
Ontario Health (Quality)
Ontario Health (Quality)
Background: The thyroid is a gland in the lower neck that is responsible for secreting hormones related to growth and metabolism. A cancer growth in the thyroid can spread to other parts of the body, but most thyroid nodu...
Clinical Trial
Ontario health technology assessment series. 2022 Apr 1;22(2):1-111. DOI: 2022
Transcatheter Valve-in-Valve Implantation for Degenerated Mitral or Tricuspid Bioprosthetic Valves: A Heath Technology Assessment [0.03%]
经导管瓣中瓣植入术治疗退变的二尖瓣或三尖瓣生物瓣膜的技术评估报告
Ontario Health (Quality)
Ontario Health (Quality)
Background: Bioprosthetic valves used to treat mitral or tricuspid valve disease can be expected to deteriorate and eventually fail after 10 to 15 years. For patients who are considered inoperable or high-risk for surgery...
Internet-Delivered Cognitive Behavioural Therapy for Post-traumatic Stress Disorder or Acute Stress Disorder: A Health Technology Assessment [0.03%]
互联网认知行为疗法在治疗创伤后应激障碍或急性应激障碍中的应用：健康技术评估
Ontario Health (Quality)
Ontario Health (Quality)
Background: Post-traumatic stress disorder (PTSD) and acute stress disorder (ASD) are mental health conditions that may emerge following a frightening or traumatic event in a person's life. We conducted a health technolog...
DPYD Genotyping in Patients Who Have Planned Cancer Treatment With Fluoropyrimidines: A Health Technology Assessment [0.03%]
氟尿嘧啶类药物治疗计划的癌症患者的DPYD基因分型健康技术评估报告
Ontario Health (Quality)
Ontario Health (Quality)
Background: Fluoropyrimidine drugs (such as 5-fluorouracil and capecitabine) are used to treat different types of cancer. However, these drugs may cause severe toxicity in about 10% to 40% of patients. A deficiency in the...
Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment [0.03%]
包含决策支持工具的多基因药物基因组学检测技术(Guiding抑郁症患者的用药选择)健康技术评估报告
Ontario Health (Quality)
Ontario Health (Quality)
Background: Major depression is a substantial public health concern that can affect personal relationships, reduce people's ability to go to school or work, and lead to social isolation. Multi-gene pharmacogenomic testing...
Enhanced Visualization Methods for First Transurethral Resection of Bladder Tumour in Suspected Non-muscle-invasive Bladder Cancer: A Health Technology Assessment [0.03%]
疑似非肌层浸润性膀胱癌患者初次经尿道膀胱肿瘤电切术的增强可视化方法：卫生技术评估报告
Ontario Health (Quality)
Ontario Health (Quality)
Background: Bladder cancer begins in the innermost lining of the bladder wall and, on histological examination, is classified as one of two types: non-muscle-invasive bladder cancer (NMIBC) or muscle-invasive bladder canc...
Meta-Analysis
Ontario health technology assessment series. 2021 Aug 12;21(12):1-123. DOI: 2021
Stance-Control Knee-Ankle-Foot Orthoses for People With Knee Instability: A Health Technology Assessment [0.03%]
膝关节不稳定患者使用的 stance-control 膝踝足矫形器：一项卫生技术评估
Ontario Health (Quality)
Ontario Health (Quality)
Background: Knee instability can arise from various causes and conditions such as neuromuscular disease, central nervous system conditions, and trauma. For people with knee instability, knee orthosis devices are prescribe...
iStent for Adults With Glaucoma: A Health Technology Assessment [0.03%]
原发性开角型青光眼患者使用iStent手术的健康技术评估报告公示版
Ontario Health (Quality)
Ontario Health (Quality)
Background: Glaucoma is a condition that causes progressive damage to the optic nerve, which can lead to visual impairment and potentially to irreversible blindness. The iStent and iStent inject are devices implanted in t...
Nonthermal Endovenous Procedures for Varicose Veins: A Health Technology Assessment [0.03%]
非热力的静脉内治疗曲张静脉的技术评估报告
Ontario Health (Quality)
Ontario Health (Quality)
Background: Varicose veins are part of the spectrum of chronic venous disease and are a sign of underlying chronic venous insufficiency. Treatments to address varicose veins include surgical vein removal under general ane...
Meta-Analysis
Ontario health technology assessment series. 2021 Jun 4;21(8):1-188. DOI: 2021